EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mitochondrial Dysfunction in Neurodegenerative Diseases: Molecular Mechanisms, Primary Drivers Versus Early Amplifiers, and Emerging Mitochondria-Targeted Therapeutic Strategies

Prarthana Kalerammana Gopalakrishna, Thirupathirao Vishnumukkala, Zaw Myo Hein iD, Barani Karikalan, Srikumar Chakravarthi iD, Farida Hussan iD, Riya Sandeep Deoghare, Saravanan Jagadeesan, Narendiran Krishnasamy, Soe Ei Phyu, Pamela David iD, Mohd Amir Kamaruzzaman iD

International Journal of Molecular Sciences · 07.11.2026 · 27 (21) · 9993

DOI: 10.3390/ijms27219993 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.11.2026. Verfasst von Prarthana Kalerammana Gopalakrishna und 11 weiteren Autor:innen. Beteiligte Einrichtung: Physiology Discipline, Human Biology Division, School of Medicine, IMU University, 126, Jln Jalil Perkasa 19, Bukit Jalil, Kuala Lumpur 57000, Federa…. Hauptthemen laut MEDLINE: Mitochondria, Neurodegenerative Diseases. Die Arbeit nennt 331 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universiti Kebangsaan Malaysia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondria are critical for bioenergetics, calcium and redox homeostasis, and apoptosis in neurons. Neurons are especially susceptible to mitochondrial malfunction since they are terminally differentiated and have extraordinary energy requirements. Mechanisms such as defective oxidative phosphorylation, altered fission-fusion dynamics, defective mitophagy, impaired axonal transport and excessive reactive oxygen species (ROS) generation are increasingly appreciated as important mechanisms in major neurodegenerative diseases (NDDs) like Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS) and Huntington’s disease (HD). The review discusses the structure and function of mitochondria with emphasis on oxidative phosphorylation, ROS and reactive nitrogen species (RNS) signalling, calcium-mediated excitotoxicity, lipid metabolism, and apoptotic and non-apoptotic cell-death mechanisms including necroptosis, ferroptosis, pyroptosis and parthanatos. In particular, disease-specific processes are highlighted, such as impaired mitophagy by amyloid β/tau in AD, PTEN-induced kinase 1 (PINK1)/Parkin dysfunction and complex I inhibition in PD, Superoxide Dismutase 1 (SOD1)/C9orf72-associated mitochondrial defects in ALS, and bioenergetic dysfunction by mutant huntingtin in HD. Therapeutic approaches include mitochondria-targeted antioxidants, fusion and biogenesis enhancers, fission inhibitors, inflammasome modulators, Mitochondrial Permeability Transition Pore (mPTP) inhibitors and gene therapy. Also highlighted are recent advancements such as Ubiquitin-Specific Peptidase 30 (USP30) inhibition, intercellular mitochondrial transfer and regulatory approval of a mitochondria-targeted peptide, together with evidence supporting causality and hurdles underpinning clinical translation. Graded against human-genetic, patient-tissue and model-based evidence, mitochondrial dysfunction is best supported as a primary driver in PD and genetic ALS, and as an early amplifier of proteinopathic or mutant-huntingtin toxicity in sporadic AD and HD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitochondriaNeurodegenerative DiseasesHumansAnimalsReactive Oxygen SpeciesMitochondrial DynamicsMitophagy

Stichwörter der Autor:innen

mitochondria-targeted antioxidantsmitochondrial dynamicsmitochondrial dysfunctionmitophagyneurodegenerationoxidative phosphorylation

Substanzen

Reactive Oxygen Species

Autor:innen und Institutionen

  • Physiology Discipline, Human Biology Division, School of Medicine, IMU University, 126, Jln Jalil Perkasa 19, Bukit Jalil, Kuala Lumpur 57000, Federal Territory of Kuala Lumpur, Malaysia.
  • Anatomy Discipline, Human Biology Division, School of Medicine, IMU University, 126, Jln Jalil Perkasa 19, Bukit Jalil, Kuala Lumpur 57000, Federal Territory of Kuala Lumpur, Malaysia.
  • Department of Basic Medical Sciences, College of Medicine, Ajman University, Ajman P.O. Box 346, United Arab Emirates.
  • Department of Pathology, Faculty of Medicine, MAHSA University, Bandar Saujana Putra, Jenjarom 42610, Selangor, Malaysia.
  • Faculty of Medicine, Nursing and Health Sciences, SEGi University, 9, Jalan Teknologi, Pju 5 Kota Damansara, Petaling Jaya 47810, Selangor, Malaysia.
  • Department of Basic Medical Sciences, Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak, Jln Datuk Mohammad Musa, Kota Samarahan 94300, Sarawak, Malaysia.

ORCID-Profile: Zaw Myo Hein, Srikumar Chakravarthi, Farida Hussan, Pamela David, Mohd Amir Kamaruzzaman

Förderung

  • Universiti Kebangsaan Malaysia

Zitieren

APA

Gopalakrishna, P. K., Vishnumukkala, T., Hein, Z. M., Karikalan, B., Chakravarthi, S., Hussan, F., Deoghare, R. S., Jagadeesan, S., Krishnasamy, N., Phyu, S. E., David, P., & Kamaruzzaman, M. A. (2026). Mitochondrial Dysfunction in Neurodegenerative Diseases: Molecular Mechanisms, Primary Drivers Versus Early Amplifiers, and Emerging Mitochondria-Targeted Therapeutic Strategies. International Journal of Molecular Sciences, 27(21), 9993. https://doi.org/10.3390/ijms27219993

Vancouver

Gopalakrishna PK, Vishnumukkala T, Hein ZM, Karikalan B, Chakravarthi S, Hussan F, et al. Mitochondrial Dysfunction in Neurodegenerative Diseases: Molecular Mechanisms, Primary Drivers Versus Early Amplifiers, and Emerging Mitochondria-Targeted Therapeutic Strategies. International Journal of Molecular Sciences. 2026;27(21):9993. doi:10.3390/ijms27219993

BibTeX
@article{Gopalakrishna2026,
  author = {Gopalakrishna, Prarthana Kalerammana and Vishnumukkala, Thirupathirao and Hein, Zaw Myo and Karikalan, Barani and Chakravarthi, Srikumar and Hussan, Farida and Deoghare, Riya Sandeep and Jagadeesan, Saravanan and Krishnasamy, Narendiran and Phyu, Soe Ei and David, Pamela and Kamaruzzaman, Mohd Amir},
  title = {Mitochondrial Dysfunction in Neurodegenerative Diseases: Molecular Mechanisms, Primary Drivers Versus Early Amplifiers, and Emerging Mitochondria-Targeted Therapeutic Strategies},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {21},
  pages = {9993},
  doi = {10.3390/ijms27219993}
}
Kostenlos starten →